Page last updated: 2024-12-07

4-methyl-3-hydroxyanthranilic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methyl-3-hydroxyanthranilic acid (4M3HA) is an important intermediate in the biosynthesis of the vitamin riboflavin. It is synthesized from chorismate by the enzyme 4-methyl-3-hydroxyanthranilate synthase (Mhas). 4M3HA is also a substrate for the enzyme riboflavin synthase, which catalyzes the final step in riboflavin biosynthesis. The importance of 4M3HA lies in its role as a precursor to riboflavin, an essential nutrient for human health. Riboflavin is a coenzyme for several important metabolic enzymes, including those involved in energy production, DNA synthesis, and red blood cell formation. Deficiencies in riboflavin can lead to a variety of health problems. Research on 4M3HA focuses on understanding its role in riboflavin biosynthesis, developing methods for its synthesis, and exploring its potential as a therapeutic agent. 4M3HA has been shown to have antioxidant and anti-inflammatory properties. However, further research is needed to determine its safety and efficacy as a therapeutic agent.'

4-methyl-3-hydroxyanthranilic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxy-4-methylanthranilic acid : An aminobenzoic acid that is anthranilic acid substituted by a hydroxy group at position 3 and a methyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID95222
CHEBI ID16116
SCHEMBL ID1005989
MeSH IDM0106322

Synonyms (18)

Synonym
CHEBI:16116
3,4-cresotic acid, 2-amino-
2-amino-3-hydroxy-4-methylbenzoic acid
4-methyl-3-hydroxyanthranilic acid
benzoic acid, 2-amino-3-hydroxy-4-methyl-
552-14-7
nsc24344
3-hydroxy-4-methylanthranilic acid
nsc-24344
C03986 ,
unii-u5azk5iee7
nsc 24344
u5azk5iee7 ,
SCHEMBL1005989
DTXSID60203691
OYZONAXDAWHDMN-UHFFFAOYSA-N
2-amino-3,4-cresotic acid
Q27098385
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monohydroxybenzoic acidAny hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.
aminobenzoic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.82 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]